Adverse Events During Hyperbaric Oxygen Therapy - Literature Review

• Autorzy: Ubysz Dorota , Giermaziak Wojciech , Ostrowska Aurelia

Identyfikatory

DOI

10.2478/phr-2021-0016

Warianty tytułu

PL

Zdarzenia niepożądane podczas tlenoterapii hiperbarycznej - przegląd piśmiennictwa

• Języki publikacji: EN PL

Abstrakty

EN

As any other therapy method, hiperbaric oxygen therapy is connected with the risk of complications. The article is a review of the results of research on adverse events of hyperbaric oxygen therapy. The most common are: borotrauma of the middle ear, paranasal sinuses or lungs, oxygen toxicity can be pulmonary, ocular in extreme cases leading to cataracts, claustrophobia, pulmonary edema or hypoglycaemia. Research has shown that these events occur in the presence of high oxygen concentration or high pressure. Depending on the severity of complications, they are short-term not causing discontinuation of therapy or long-term excluding continuation of treatment. However adverse events connected with oxygen therapy are not common and are usually mild. This confirms that HBOT is an effective and safe method of treating decompression sickness, carbon monoxide poisoning, and the treatment of chronic wounds, delayed radiation injuries or necrotic soft tissue infections.

PL

Tlenoterapia hiperbaryczna jak każda metoda terapii niesie ryzyko powikłań. Artykuł stanowi przegląd wyników badań dotyczących zdarzeń niepożądanych tlenoterapii hiperbarycznej. Do najczęstszych należą: borotrauma ucha środkowego, zatok przynosowych czy płuc, toksyczność tlenowa może być płucna, oczna w skrajnych przypadkach prowadząca do zaćmy, klaustrofobia, obrzęk płuc czy hipoglikemia. Jak wykazały badania, do zdarzeń tych dochodzi w przypadku wysokiego stężenia lub wysokiego ciśnienia tlenu. W zależności od ciężkości powikłań są one krótkotrwałe nie powodujące przerwania terapii oraz długotrwałe wykluczające kontynuowanie leczenia. Jednakże zdarzenia niepożądane związane z tlenoterapią występują rzadko i są przeważnie łagodne, co potwierdza, że HBOT jest skuteczną i bezpieczną metodą leczenia zarówno choroby dekompresyjnej, zatruć tlenkiem węgla, czy leczeniem ran przewlekłych, opóźnionych urazów popromiennych czy martwiczych infekcji tkanek miękkich.

Słowa kluczowe

EN

hiperbaric oxygen therapy; HBOT; safety; complications of oxygen therapy

PL

tlenoterapia hiperbaryczna; HBOT; bezpieczeństwo; powikłania tlenoterapii

• Wydawca: Polskie Towarzystwo Medycyny i Techniki Hiperbarycznej
• Czasopismo: Polish Hyperbaric Research
• Rocznik: 2021
• Tom: nr 3(76)
• Strony: 45--66
• Opis fizyczny: Bibliogr. 30 poz.

Twórcy

autor

Ubysz Dorota

• Main Medical Library in Warsaw, Poland

autor

Giermaziak Wojciech

• Main Medical Library in Warsaw, Poland

autor

Ostrowska Aurelia

• Military Medical Service Department in Warsaw, Poland

Bibliografia

• 1. Bessereau J, Aboab J, Hullin T, Huon-Bessereau A, Bourgeois JL, Brun PM, Chevret S, Annane D: Safety of hyperbaric oxygen therapy in mechanically ventilated patients. International Maritime Health. 68(1):46-51, 2017.
• 2. Corcoran T, Ting S, Mas E, Phillips M, O'Loughlin E, Barden A, Mori TA: Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans. Prostaglandins Leukotrienes & Essential Fatty Acids. 127:16-19, 2017.
• 3. Caplan M, Duburcq T, Moreau AS, Poissy J, Nseir S, Parmentier-Decrucq E: Hyperbaric hyperoxemia as a risk factor for ventilator-acquired pneumonia?. PLoS ONE [Electronic Resource]. 16(6):e0253198, 2021.
• 4. Chen JM, Lu ZN, Wu RW, Bi KW, Liu CT: Effect of self-acupressure on middle ear barotrauma associated with hyperbaric oxygen therapy: A nonrandomized clinical trial. Medicine. 100(17):e25674, 2021.
• 5. Dejmek J, Kohoutova M, Kripnerova M, Cedikova M, Tuma Z, Babuska V, Bolek L, Kuncova J: Repeated exposure to hyperbaric hyperoxia affects mitochondrial functions of the lung fibroblasts. Physiological Research. 67(Suppl 4):S633-S643, 2018 12 31.
• 6. Kobielska E, Chrapusta A: Sześcioletnia analiza powikłań terapii tlenem hiperbarycznym u 1981 pacjentów. Chirurgia Plastyczna i oparzenia. 2020; 8(1): 1-5.
• 7. Jokinen-Gordon H, Barry RC, Watson B, Covington DS: A Retrospective Analysis of Adverse Events in Hyperbaric Oxygen Therapy (2012-2015): Lessons Learned From 1.5 Million Treatments. Advances in Skin & Wound Care. 30(3):125-129, 2017.
• 8. Lin CH, Su WH, Chen YC, Feng PH, Shen WC, Ong JR, Wu MY, Wong CS: Treatment with normobaric or hyperbaric oxygen and its effect on neuropsychometric dysfunction after carbon monoxide poisoning: A systematic review and meta-analysis of randomized controlled trials. Medicine. 97(39):e12456, 2018.
• 9. Cho K, Minami T, Okuno Y, Kakuda Y, Tsutsumi T, Kogame T, Ohtsuru S, Sato N, Koike K: Convulsive seizure and pulmonary edema during hyperbaric oxygen therapy:A case report. Journal of Medical Investigation. 65(3.4):286-288, 2018.
• 10. Heyboer M., Sharma D., Santiago W., McCulloch N.: Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified. ADVANCES IN WOUND CARE, VOLUME 6, NUMBER 6, 2017.
• 11. Meng FC, Shen CH, Chu CM, Shih CP, Lin HC, Peng CK, Chang SC, Huang KL: Dried salted plum consumption ameliorates hyperbaric oxygen therapy-induced otalgia severity at the first chamber session: a prospective randomized controlled study. Undersea & Hyperbaric Medicine. 44(6):551-557, 2017.
• 12. Yamamoto Y, Asai N, Furuhashi A, Ono T, Yamagishi Y, Mikamo H, Kazaoka Y: Metronidazole-induced encephalopathy caused by hyperbaric oxygen therapy in a patient with mandibular osteomyelitis. Journal of Infection & Chemotherapy. 25(12):1057-1059, 2019.
• 13. Evanger K, Vaagbo G, Haugen OH: Short-term effects on ocular variables immediately after hyperbaric oxygen exposures. Undersea & Hyperbaric Medicine. 45(4):395-402, 2018.
• 14. Hagan JC, Maturo JV, Kirby JP: Rapidly Developing Large Bilateral Cataracts in a 58-Year-Old Woman After Only 46 Hyperbaric Oxygen Treatments. Missouri Medicine. 116(5):396-399, 2019.
• 15. Moon RE: UHMS HBO2 committee chair questions FDA on incorrect info. Undersea & Hyperbaric Medicine. 44(6):611-612, 2017.
• 16. Ng AWA, Muller R, Orton J: Incidence of middle ear barotrauma in staged versus linear chamber compression during hyperbaric oxygen therapy: a double blinded, randomized controlled trial. Undersea & Hyperbaric Medicine. 44(2):101-107, 2017.
• 17. Tran V, Smart D: Proliferative retinopathy during hyperbaric oxygen treatment. Diving & Hyperbaric Medicine. 47(3):203, 2017.
• 18. Uluyol S, Demir L, Kilicaslan S: The Effects of Short- and Long-Term Exposure to Hyperbaric Oxygen on Nasal Mucociliary Clearance. Journal of Craniofacial Surgery. 28(2):331-333, 2017.
• 19. Wang KY, Lin YS, Sy CL, Huang WC, Chen LW: Hyperbaric oxygen therapy increases the risk of tuberculosis disease. International Journal of Tuberculosis & Lung Disease. 22(6):637-640, 2018 06 01.
• 20. Warchol JM, Cooper JS, Diesing TS: Hyperbaric oxygen-associated seizure leading to stroke. Diving & Hyperbaric Medicine. 47(4):260-262, 2017.
• 21. Lee CH, Choi JG, Lee JS, Lee Y, Kim H, Kim YS, Cha YS: Seizure during hyperbaric oxygen therapy: experience at a single academic hospital in Korea. Undersea & Hyperbaric Medicine. 48(1):43-51, 2021.
• 22. Edinguele WFOP, Barberon B, Poussard J, Thomas E, Reynier JC, Coulange M: Middle-ear barotrauma after hyperbaric oxygen therapy: a five-year retrospective analysis on 2,610 patients. Undersea & Hyperbaric Medicine. 47(2):217-228, 2020.
• 23. Churchill S, Deru K, Weaver LK, Wilson SH, Hebert D, Miller RS, Lindblad AS: Adverse events and blinding in two randomized trials of hyperbaric oxygen for persistent post-concussive symptoms. Undersea & Hyperbaric Medicine. 46(3):331-340, 2019 BIMA Special Edition No. Feb.
• 24. Nasole E, Zanon V, Marcolin P, Bosco G: Middle ear barotrauma during hyperbaric oxygen therapy; a review of occurrences in 5,962 patients. Undersea & Hyperbaric Medicine. 46(2):101-106, 2019.
• 25. Fan D, Lv Y, Hu H, Pan S: Severe pulmonary edema following hyperbaric oxygen therapy for acute carbon monoxide poisoning: a case report and clinical experience. Undersea & Hyperbaric Medicine. 44(3):287-291, 2017.
• 26. Gariel C, Delwarde B, Beroud S, Soldner R, Floccard B, Rimmele T: Is decompression illness possible during hyperbaric therapy? a case report. Undersea & Hyperbaric Medicine. 44(3):283-285, 2017.
• 27. Heyboer Rd M, Wojcik SM, Smith G, Santiago W: Effect of hyperbaric oxygen therapy on blood pressure in patients undergoing treatment. Undersea & Hyperbaric Medicine. 44(2):93-99, 2017.
• 28. Cohn JE, Pfeiffer M, Patel N, Sataloff RT, McKinnon BJ: Identyfying eustachian tube dysfunction prior to hyperbaric oxygen therapy: Who is risk for intolerance? American Journal of Otolaryngology-Head and Neck Medicine and Surgery. 39(1):14-19, 2018.
• 29. Lu LQ, Strauss MB, Miller SS: The Gradient Perfusion Model Part 3: An extraordinary case of decompression sickness. Undersea & Hyperbaric Medicine. 45(3):307-311, 2018.
• 30. Poolpol P, Sithisarankul P, Rattananupong T: Lung function change in hyperbaric chamber inside attendants. International Maritime Health. 70(2):125-131, 2019.